A Risk–Benefit Assessment of Prasugrel, Clopidogrel, and Genotype-Guided Therapy in Patients Undergoing Percutaneous Coronary Intervention
Research output: Contribution to journal › Article › peer-review
Electronic versions
DOI
| Original language | English |
|---|---|
| Journal | Clinical Pharmacology and Therapeutics |
| DOIs | |
| Publication status | Published - 28 Mar 2012 |